Kopion Asset Management LLC Acquires 39,891 Shares of Cognex Corporation $CGNX

Key Points

• Kopion Asset Management LLC increased its stake in Cognex Corporation by 16.3% during Q2, now holding a total of 284,193 shares valued at approximately $9 million.
• Other institutional investors, such as T. Rowe Price and Mackenzie Financial Corp, also significantly increased their holdings in Cognex by 32.0% and 126.2%, respectively, during the first quarter.
• Cognex recently reported earnings of $0.25 per share, exceeding analysts' expectations, along with a quarterly dividend of $0.08, reflecting a 0.7% dividend yield.

Kopion Asset Management LLC lifted its holdings in Cognex Corporation (NASDAQ:CGNX - Free Report) by 16.3% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 284,193 shares of the scientific and technical instruments company's stock after buying an additional 39,891 shares during the quarter. Cognex makes up 6.1% of Kopion Asset Management LLC's portfolio, making the stock its 9th biggest position. Kopion Asset Management LLC owned approximately 0.17% of Cognex worth $9,015,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. T. Rowe Price Investment Management Inc. lifted its holdings in Cognex by 32.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock worth $181,436,000 after acquiring an additional 1,474,832 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Cognex by 126.2% in the 1st quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock worth $137,510,000 after purchasing an additional 2,571,457 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Cognex by 34.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company's stock worth $75,756,000 after purchasing an additional 647,955 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Cognex by 1.9% during the 1st quarter. Bank of New York Mellon Corp now owns 2,131,538 shares of the scientific and technical instruments company's stock valued at $63,584,000 after purchasing an additional 38,857 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in Cognex by 5.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,507,022 shares of the scientific and technical instruments company's stock worth $44,954,000 after buying an additional 79,266 shares during the last quarter. Institutional investors own 88.12% of the company's stock.

Insiders Place Their Bets

In related news, EVP Sheila Marie Dipalma sold 2,002 shares of Cognex stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $45.00, for a total transaction of $90,090.00. Following the transaction, the executive vice president directly owned 8,582 shares of the company's stock, valued at $386,190. The trade was a 18.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by corporate insiders.

Cognex Trading Down 1.2%

Shares of NASDAQ:CGNX opened at $44.39 on Monday. The company has a 50 day moving average of $39.81 and a 200-day moving average of $33.04. The firm has a market cap of $7.45 billion, a P/E ratio of 62.52 and a beta of 1.50. Cognex Corporation has a twelve month low of $22.67 and a twelve month high of $45.23.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $249.09 million for the quarter, compared to analysts' expectations of $246.70 million. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The firm's quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Equities research analysts forecast that Cognex Corporation will post 0.61 EPS for the current year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were issued a $0.08 dividend. The ex-dividend date was Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. Cognex's dividend payout ratio is 45.07%.

Analysts Set New Price Targets

CGNX has been the topic of a number of recent research reports. DA Davidson raised their target price on Cognex from $32.00 to $35.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. The Goldman Sachs Group boosted their target price on shares of Cognex from $29.00 to $32.00 and gave the company a "sell" rating in a research note on Thursday, June 12th. Citigroup restated a "neutral" rating and issued a $37.00 target price (up previously from $30.00) on shares of Cognex in a research report on Monday, July 14th. KeyCorp raised Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target on the stock in a report on Friday, August 1st. Finally, Robert W. Baird increased their price objective on Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a report on Monday, June 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $42.31.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.